Skip to main content

Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Interest Expense (QFR105385USNO)

Observation:

Q4 2023: 7,665 (+ more)  Updated: 9:09 AM CDT
Q4 2023:  7,665  
Q3 2023:  7,316  
Q2 2023:  6,671  
Q1 2023:  5,999  
Q4 2022:  5,981  

Units:

Millions of Dollars,
Not Seasonally Adjusted

Frequency:

Quarterly

NOTES

Title Release Dates

2017-09-06 2024-03-18
 
Source    

2017-09-06 2024-03-18
 
Release    

2017-09-06 2024-03-18
 
Units    

2017-09-06 2024-03-18
 
Frequency    

2017-09-06 2024-03-18
 
Seasonal Adjustment    

2017-09-06 2024-03-18
 
Notes    

2017-09-06 2024-03-18

Subscribe to the FRED newsletter

Follow us

Back to Top
Top